PAI

Palo Alto Investors Portfolio holdings

AUM $470M
1-Year Return 2.57%
This Quarter Return
-11.21%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.5B
AUM Growth
-$556M
Cap. Flow
-$199M
Cap. Flow %
-13.23%
Top 10 Hldgs %
68.56%
Holding
39
New
–
Increased
–
Reduced
23
Closed
2

Top Buys

No buys this quarter

Top Sells

1
EXAS icon
Exact Sciences
EXAS
+$37.2M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$26.8M
3
SAGE
Sage Therapeutics
SAGE
+$16M
4
INSM icon
Insmed
INSM
+$11.5M
5
UTHR icon
United Therapeutics
UTHR
+$10.2M

Sector Composition

1 Healthcare 87%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GILD icon
26
Gilead Sciences
GILD
$142B
$2.49M 0.17%
39,300
-136,600
-78% -$8.66M
CELG
27
DELISTED
Celgene Corp
CELG
$2.17M 0.14%
21,883
-85,000
-80% -$8.44M
ALIM
28
DELISTED
Alimera Sciences, Inc.
ALIM
$1.71M 0.11%
200,920
– –
CYTK icon
29
Cytokinetics
CYTK
$6.12B
$1.41M 0.09%
123,686
– –
ZGNX
30
DELISTED
Zogenix, Inc.
ZGNX
$1.18M 0.08%
29,500
– –
VIRX
31
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$837K 0.06%
33,214
– –
ALDX icon
32
Aldeyra Therapeutics
ALDX
$324M
$387K 0.03%
73,500
– –
NERV icon
33
Minerva Neurosciences
NERV
$15.2M
$281K 0.02%
4,540
– –
ACGN
34
DELISTED
Aceragen, Inc. Common Stock
ACGN
$223K 0.01%
4,537
– –
MRNS
35
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$193K 0.01%
31,330
– –
SPHS
36
DELISTED
Sophiris Bio, Inc.
SPHS
$144K 0.01%
247,000
– –
MLNT
37
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$39K ﹤0.01%
10,137
– –
EXAS icon
38
Exact Sciences
EXAS
$10.2B
– –
-314,889
Closed -$37.2M
OCGN icon
39
Ocugen
OCGN
$334M
– –
-5,049
Closed -$58K
1
2